Here are 14 key notes on major spine and orthopedic device companies.
Bacterin International announced second quarter preliminary unaudited financial results, and total net revenue for the second quarter is anticipated at $8.75 million to $8.85 million.
BioDelivery Sciences International named Charles J. Bramlage and Barry I. Feinberg, MD, to the board of directors.
ConforMIS announced results from a clinical study evaluating hospital outcomes and costs in patients undergoing total knee arthroplasty using ConforMIS iTotal customized knee implants compared with standard, off-the-shelf implants.
Ellipse Technologies' MAGnetic Expansion Control or MAGEC system received strong recommendations from the National Institute for Health and Care Excellence, an independent body in Britain responsible for driving improvement and excellence in the health and social care system, and the British National Health Service.
IMPLANET's board of directors nominated Paula Ness Speers as a new independent advisor.
K2M held four educational workshops during the 21st International Meeting on Advanced Spine Techniques in Valencia, Spain, and the company reported more than 300 participants.
Surgical technology company MedTech, based in Toulouse, France, received CE approval to begin marketing its spinal surgery robot ROSA Spine in Europe.
Medtronic shareholders filed a lawsuit in early July at the Hennepin County District Court in opposition to the company's $42.9 billion acquisition of Covidien.
Orthofix had a busy month in June with a huge increase in short interest shares sold — by the end of the month, short interest sold totaled 891,986 shares, a 37.3 percent increase from June 13 to June 30.
Stryker appointed President and CEO Kevin A Lobo to Chairman of the Board.
Zacks reiterated a "neutral" rating for Stryker and set a target price of $86 on the company's stock.
Stryker released its financial report last week, reporting 6.8 percent growth in net sales for $2.4 billion in the quarter.
The Scoliosis Research Society granted medical device company Titan Spine the Whitecloud Award for Best Basic Science Research.
Trice Medical closed the first portion of an $11.6 million series B financing round and appointed Jeffrey F. O'Donnell Sr. to the role of chairman and CEO.
More Articles on Devices:
5 Key Results: LDR's Mobi-C Artificial Disc Replacement vs. ACDF
FDA Clears AccelSPINE's Next Generation Minimally Invasive Spine System
Global Medical Device Market to Grow at 6.2% Annually Until 2018